Trial Profile
A Phase 1 Open-label, Single-sequence Study to Evaluate the Effect of Coadministration of BMS-919373 on the Single-dose Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Oct 2014
Price :
$35
*
At a glance
- Drugs BMS 919373 (Primary) ; Atorvastatin; Rosuvastatin
- Indications Acute coronary syndromes
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 17 Jul 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 24 Mar 2014 New trial record